The global MENA Biologics & Biosimilars Market is estimated to be valued at US$ 442.5 Mn in 2020 and is expected to exhibit a CAGR of 3.9% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.
A) Market Overview:
The MENA Biologics & Biosimilars market refers to the market for biologic drugs and biosimilars in the Middle East and North Africa region. Biologic drugs are complex therapeutic proteins that are ... Read more
